|
I'm happy very good site https://www.reggaemarathon.com/acceleron-pharma-inc-stock-50d8.pdf acceleron pharma pipeline The company's ultimate aim is to bring equality of treatment and a reduction of costs to the healthcare system, and it has chosen to target fertility first because according to its data, the fertility treatment industry in the U.S. generates $5 billion a year, partly because such treatments are elective -- not covered in standard health insurance policies -- and partly because of a seeming lack of control or access to relevant information that would make conception simpler.
|